The Firm is representing China National Chemical Corporation (ChemChina) in connection with the completion of the first settlement of ChemChina’s tender offer for the Swiss agrochemical and seeds company Syngenta AG (NYSE: SYT; SWX: SYNN). Shareholders who tendered their shares by May 4, 2017 received the consideration of US$465 per share, and holders of American Depositary Shares ("ADSs") who tendered their ADSs received US$93 per ADS, on May 18, 2017. Shareholders who tender their shares or ADSs by the end of the additional acceptance period on May 24, 2017 will receive the same consideration in the second settlement, which is expected to occur on June 7, 2017.
The Simpson Thacher team includes Shaolin Luo, Yang Wang, Amy Liu, Jun Feng, Vincent Zhou and Xiaoyu Ding (M&A – Beijing); Alan Klein, Jonathan Stradling and Matthew Kemp (M&A – New York); Christopher May (M&A – Houston); Celia Lam, Venus Lo and Carol Chan (Corporate – Hong Kong); Peter Thomas and David Shogren (CFIUS – Washington, D.C.); David E. Vann Jr, Étienne Renaudeau, Pauline Patat, Alessia de Quincey and John Skinner (Antitrust – London); Peter Guryan, Ellen Frye, Daniel Owsley and Sarah Sheridan (Antitrust – New York); Jonathan Y. Mincer (Antitrust – Palo Alto); Katie Geraghty (Banking and Credit – London); and Jackie Kahng and Christian Jackson (Financing – Hong Kong).